巨星醫療控股(02393.HK)中期盈轉虧至6.4億元
格隆匯8月26日丨巨星醫療控股(02393.HK)公佈,截至2020年6月30日止六個月,實現收益16億元人民幣(單位下同),同比減少29.94%; 歸屬於母公司擁有人期內淨虧6.4億元,去年則溢利1.42億元,盈轉虧;基本及攤薄每股淨虧27.05分;不派息。
憑藉卓越的增值服務,集團已與一眾醫院建立緊密關係,有助取得用户意見反饋、病患統計數據、疾病趨勢等資料。然後,集團將協助其策略性夥伴分析該等市場數據,以助其後續研發。
得到更佳及客製化的產品,上游夥伴將能提供更佳的產品,提高利潤,繼而可動用更多資源支持產品經銷工作。儘管2020年上半年受疫情影響,集團增長放緩,惟對其長遠業務前景仍然抱有信心,將實行前述策略,力求市場增長。財政狀況得以增強,維持穩健,巨星將可於產業鏈上繼續創造價值,為其股東帶來豐碩業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.